436. Efficacy of valganciclovir plus cytomegalovirus immune globulin for prevention of cytomegalovirus disease in high risk renal transplant recipients.

  • Bitterman, Amanda N. Pharm., D., Candidate, 2013
  • Maldonado, Angela Q. Pharm.D., BCPS
  • Ojogho, Okechukwu N. M.D.
  • Siegel, Ruby M.S.
  • Weeks, Douglas L. Ph.D.

  • (1) Washington State University, Spokane, WA

    (2) Providence Sacred Heart Medical Center & Children's Hospital, Spokane, WA

Pharmacotherapy: The Journal Of Human Pharmacology & Drug Therapy 32(10):p e305, October 2012.
Copyright © 2012 John Wiley & Sons, Inc.